XML 25 R13.htm IDEA: XBRL DOCUMENT v3.22.4
MARKETABLE SECURITIES
12 Months Ended
Dec. 31, 2022
Marketable Securities Abstract  
MARKETABLE SECURITIES

5. MARKETABLE SECURITIES:

Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at December 31, 2022, were as follows:

Amortized

Gross Unrealized

Estimated Fair

(In thousands)

    

Cost

    

Gains

    

Losses

    

Market Value

Investments due in 3 months or less:

 

  

 

  

 

  

 

  

Corporate securities

$

21,803

$

$

(135)

$

21,668

Total

 

21,803

 

 

(135)

 

21,668

Investments due in 4-12 months:

 

  

 

  

 

  

 

  

Corporate securities

 

173,833

 

 

(4,019)

 

169,814

Total

 

173,833

 

 

(4,019)

 

169,814

Investments due in 12 months or greater:

 

  

 

  

 

  

 

  

Corporate securities

 

58,128

 

71

 

(1,240)

 

56,959

Total

58,128

 

71

(1,240)

 

56,959

Total marketable securities

$

253,764

$

71

$

(5,394)

$

248,441

Accrued interest receivable was $1.2 million at December 31, 2022 and was recorded within prepaid expenses and other current assets on the consolidated balance sheet.

Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at December 31, 2021, were as follows:

Amortized

Gross Unrealized

Estimated Fair

(In thousands)

    

Cost

    

Gains

    

Losses

    

Market Value

Investments due in 3 months or less:

 

  

 

  

 

  

 

  

Commercial paper

$

89,965

$

$

$

89,965

Corporate securities

7,285

(3)

7,282

Total

 

97,250

 

 

(3)

 

97,247

Investments due in 4-12 months:

 

  

 

  

 

  

 

  

Corporate securities

 

25,054

 

 

(42)

 

25,012

Total

 

25,054

 

 

(42)

 

25,012

Investments due in 12 months or greater:

 

  

 

  

 

  

 

  

Corporate securities

251,096

 

21

 

(1,141)

 

249,976

Total

 

251,096

 

21

 

(1,141)

 

249,976

Total marketable securities

$

373,400

$

21

$

(1,186)

$

372,235

Accrued interest receivable was $1.5 million at December 31, 2021 and was recorded within prepaid expenses and other current assets on the consolidated balance sheet.

As of December 31, 2022 and 2021 the Company had no marketable securities classified as available-for-sale (excluding cash equivalents) in a continuous unrealized loss position for which an allowance for credit losses was recorded. The following table summarizes marketable securities classified as available-for-sale (excluding cash equivalents) in a continuous unrealized loss position for which an allowance for credit losses was not recorded at December 31, 2022 and December 31, 2021:

Less Than 12 Months

12 Months or Longer

Total

    

Estimated

    

Gross

    

Estimated

    

Gross

    

Estimated

    

Gross

Fair Market

Unrealized

Fair Market

Unrealized

Fair Market

Unrealized

(In thousands)

Value

Losses

Value

Losses

Value

Losses

December 31, 2022

 

  

 

  

 

  

 

  

 

  

 

  

Corporate securities

$

45,047

$

(662)

$

191,443

$

(4,732)

$

236,490

$

(5,394)

Total marketable securities

$

45,047

$

(662)

$

191,443

$

(4,732)

$

236,490

$

(5,394)

Less Than 12 Months

12 Months or Longer

Total

    

Estimated

    

Gross

    

Estimated

    

Gross

    

Estimated

    

Gross

Fair Market

Unrealized

Fair Market

Unrealized

Fair Market

Unrealized

(In thousands)

Value

Losses

Value

Losses

Value

Losses

December 31, 2021

 

  

 

  

 

  

 

  

 

  

 

  

Corporate securities

$

274,380

$

(1,186)

$

$

$

274,380

$

(1,186)

Total marketable securities

$

274,380

$

(1,186)

$

$

$

274,380

$

(1,186)

The weighted average interest rate of investments at December 31, 2022 and 2021, was approximately 2.08% and 0.45%, respectively. In the years ended December 31, 2022 and 2021, no unrealized losses on marketable securities were recognized in income.